A Phase 3, Single Arm, Open Label Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis Who Are 18 to 50 Years of Age and at Risk of Pregnancy/MVT-601-050
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Cherry Creek Medical Center
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 22-1377
More information available at ClinicalTrials.gov: NCT04756037
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers